Works matching Hormone antagonists

Results: 2563

Differences in sex hormone recovery profile after cessation of 12‐week gonadotropin‐releasing hormone antagonist versus agonist therapy.

Published in:

Andrology, 2022, v. 10, n. 2, p. 270, doi. 10.1111/andr.13107

By:

Sasaki, Hiroshi;
Miki, Kenta;
Tashiro, Kojiro;
Mori, Keiichiro;
Urabe, Fumihiko;
Fukuokaya, Wataru;
Kimura, Takahiro;
Sato, Shun;
Takahashi, Hiroyuki;
Aoki, Manabu;
Egawa, Shin

Publication type:

Article

Morphofunctional State of the Ovaries in Rats with Experimental Model of Functional Cysts and Their Treatment with Gonadotropin-Releasing Hormone Antagonist.

Published in:

Bulletin of Experimental Biology & Medicine, 2024, v. 176, n. 3, p. 407, doi. 10.1007/s10517-024-06034-x

By:

Timofeeva, O. S.;
Logvinov, S. V.;
Petrov, I. A.;
Tikhonovskaya, O. A.;
Samoilova, Yu. G.;
Gaifulina, Zh. F.;
Mustafina, L. R.;
Petrova, M. S.;
Zhdankina, A. A.;
Kutsenko, I. G.;
Kudlay, D. A.;
Sidorenkova, K. A.

Publication type:

Article

Luteinizing hormone-based modified GnRH antagonist protocol in normal responders undergoing in vitro fertilization treatment: A multi-center randomized controlled trial.

Published in:

Frontiers in Endocrinology, 2022, v. 13, p. 1, doi. 10.3389/fendo.2022.922950

By:

Shan Liu;
Yasu Lv;
Minghui Liu;
Shuo Han;
Xiaoqun Liu;
Zhiming Zhao;
Wei Cui;
Aijun Yang;
Yuan Li

Publication type:

Article

Safety, pharmacokinetics, and pharmacodynamics of SHR7280, an oral gonadotropin-releasing hormone antagonist in healthy premenopausal women.

Published in:

Frontiers in Pharmacology, 2022, v. 13, p. 1, doi. 10.3389/fphar.2022.1027648

By:

Yi Xu;
Wei Hu;
Jian Li;
Xin Jiang;
Ping Shi;
Kai Shen;
Yu Shen;
Lingyu Ma;
Yu Cao

Publication type:

Article

Effect of progesterone/estradiol ratio on pregnancy outcome of patients with high trigger-day progesterone levels undergoing gonadotropin-releasing hormone antagonist intracytoplasmic sperm injection cycles: a retrospective cohort study.

Published in:

2019

By:

Golbasi, Hakan;
Ince, Onur;
Golbasi, Ceren;
Ozer, Mehmet;
Demir, Mustafa;
Yilmaz, Bulent

Publication type:

journal article

Original delayed-start ovarian stimulation protocol with a gonadotropin-releasing hormone antagonist, medroxyprogesterone acetate, and high-dose gonadotropin for poor responders and patients with poor-quality embryos.

Published in:

Frontiers in Endocrinology, 2023, p. 1, doi. 10.3389/fendo.2023.1277873

By:

Kazuhiro Takeuchi;
Yuji Orita;
Tokiko Iwakawa;
Yukari Kuwatsuru;
Yuko Kuroki;
Yumiko Fukumoto;
Yamato Mizobe;
Mari Tokudome;
Harue Moewaki

Publication type:

Article

Efficacy and Safety of Neoadjuvant Luteinizing Hormone-Releasing Hormone Antagonist and Tegafur-Uracil Chemohormonal Therapy for High-Risk Prostate Cancer.

Published in:

Life (2075-1729), 2023, v. 13, n. 5, p. 1072, doi. 10.3390/life13051072

By:

Sugino, Fumiya;
Nakane, Keita;
Kawase, Makoto;
Ueda, Shota;
Tomioka, Masayuki;
Takeuchi, Yasumichi;
Tomioka-Inagawa, Risa;
Yamada, Toyohiro;
Namiki, Sanae;
Kumada, Naotaka;
Takeuchi, Shinichi;
Kawase, Kota;
Kato, Daiki;
Takai, Manabu;
Iinuma, Koji;
Tobisawa, Yuki;
Koie, Takuya

Publication type:

Article

Fixed Gonadotropin-Releasing Hormone Antagonist Protocol Versus Flexible Progestin-Primed Ovarian Stimulation Protocol in Patients With Asynchronous Follicular Development During Controlled Ovulation Stimulation: A Retrospective Study.

Published in:

Frontiers in Endocrinology, 2021, v. 12, p. 1, doi. 10.3389/fendo.2021.690575

By:

Dong, Mei;
Sun, Li;
Huang, Li;
Wang, Fang;
Zhang, Xiqian;
Liu, Fenghua

Publication type:

Article

Pregnancy co-treated with oral gonadotropin-releasing hormone antagonist in a woman with premature ovarian insufficiency: a case report.

Published in:

2024

By:

Daichi Inoue;
Manami Kondo;
Rie Mizuno;
Shinichi Shibuya;
Yoshiki Hashiba;
Yoshimasa Asada

Publication type:

Case Study

Safety, pharmacokinetics, and pharmacodynamics of SHR7280, an oral gonadotropin-releasing hormone receptor antagonist, in healthy men: a randomized, double-blind, placebo-controlled phase 1 study.

Published in:

BMC Medicine, 2023, v. 21, n. 1, p. 1, doi. 10.1186/s12916-023-02834-6

By:

Li, Xin;
Sun, Feifei;
Zhang, Xiaolei;
Lin, Pingping;
Shen, Kai;
Shen, Yu;
Ma, Lingyu;
Cao, Yu;
Wang, Chenjing

Publication type:

Article

A phase 2a, randomized, double-blind, placebo-controlled trial of the efficacy and safety of the oral gonadotropin-releasing hormone antagonist, ASP1707, in postmenopausal female patients with rheumatoid arthritis taking methotrexate.

Published in:

Modern Rheumatology, 2021, v. 31, n. 1, p. 53, doi. 10.1080/14397595.2020.1733214

By:

Tsutomu Takeuchi;
Yoshiya Tanaka;
Chieri Higashitani;
Megumi Iwai;
Kanji Komatsu;
Rio Akazawa;
Lademacher, Christopher

Publication type:

Article

Pituitary block with gonadotrophin-releasing hormone antagonist during intrauterine insemination cycles: a systematic review and meta-analysis of randomised controlled trials.

Published in:

2019

By:

Vitagliano, A;
Saccone, G;
Noventa, M;
Borini, A;
Coccia, ME;
Nardelli, GB;
Saccardi, C;
Bifulco, G;
Litta, PS;
Andrisani, A;
Coccia, M E;
Nardelli, G B;
Litta, P S

Publication type:

journal article

Successful outcome of a pregnancy derived from premature ovulation in a gonadotropin‐releasing hormone antagonist protocol: A case report.

Published in:

Clinical Case Reports, 2021, v. 9, n. 2, p. 883, doi. 10.1002/ccr3.3689

By:

Inoue, Daichi;
Asada, Yoshimasa;
Ando, Tomoko

Publication type:

Article

Effect of body mass index on progesterone level on trigger day in gonadotropin-releasing hormone antagonist cycles.

Published in:

Gynecological Endocrinology, 2024, v. 40, n. 1, p. 1, doi. 10.1080/09513590.2024.2364892

By:

Sun, Yating;
Zhu, Aizhen

Publication type:

Article

Effects of increasing serum luteinizing hormone levels during early phase of the gonadotropin-releasing hormone antagonist protocol on clinical outcomes of the in vitro fertilization cycle.

Published in:

Gynecological Endocrinology, 2022, v. 38, n. 2, p. 135, doi. 10.1080/09513590.2021.1955341

By:

Huang, Qianwen;
Nong, Yingqi;
Zhang, Xiqian;
Huang, Li;
Tang, Ting;
Huang, Ju;
Liu, Fenghua

Publication type:

Article

Infertile polycystic ovary syndrome patients undergoing in vitro fertilization with the gonadotropin-releasing hormone-antagonist protocol: role of hyperandrogenism.

Published in:

Gynecological Endocrinology, 2018, v. 34, n. 8, p. 715, doi. 10.1080/09513590.2018.1431773

By:

Yang, Wan;
Yang, Rui;
Yang, Shuo;
Li, Jia;
Tu, Binbin;
Gao, Chang;
Wang, Ying

Publication type:

Article

Evaluation of pregnancy outcomes using medroxyprogesterone acetate versus gonadotropin-releasing hormone antagonist in ovarian stimulation: A retrospective cohort study.

Published in:

International Journal of Reproductive Biomedicine, 2022, v. 20, n. 6, p. 491, doi. 10.18502/ijrm.v20i6.11445

By:

Singh, Ekika;
Blockeel, Christophe;
Singh, Madhulika;
Gupta, Rishi;
Kamdi, Sandesh

Publication type:

Article

Luteinizing hormone changes in gonadotropin-releasing hormone antagonist protocol in in vitro fertilization cycles: A cross-sectional study.

Published in:

International Journal of Reproductive Biomedicine, 2019, v. 17, n. 3, p. 209, doi. 10.18502/ijrm.v17i3.4520

By:

Rashidi, Batool Hosein;
Kabodmehri, Roya;
Shariat, Mamak;
Tehraninejad, Shahrokh;
Abdollahi, Alireza;
Bagheri, Maryam;
Hagholahi, Fedieh

Publication type:

Article

Luteinizing hormone-releasing hormone receptor agonists and antagonists in prostate cancer: effects on long-term survival and combined therapy with next-generation hormonal agents.

Published in:

Cancer Biology & Medicine, 2024, v. 21, n. 11, p. 1012, doi. 10.20892/j.issn.2095-3941.2024.0139

By:

Jinge Zhao;
Junru Chen;
Guangxi Sun;
Pengfei Shen;
Hao Zeng

Publication type:

Article

The Effects of Human Chorionic Gonadotropin and Gonadotropin-Releasing Hormone Receptor Antagonist on Testicular Steroidogenesis in Normal and Obese Rats.

Published in:

Bulletin of Experimental Biology & Medicine, 2024, v. 177, n. 4, p. 436, doi. 10.1007/s10517-024-06204-x

By:

Lebedev, I. A.;
Kuznetsova, V. S.;
Bakhtyukov, A. A.;
Shpakov, A. O.

Publication type:

Article

Effect of Gonadotropin-Releasing Hormone Antagonist on the Expression Patterns of Insulin-Like Growth Factor 1, Androgen Receptor, and Luteinizing Hormone Receptor in an Experimental Rat Model of Functional Ovarian Cysts.

Published in:

Bulletin of Experimental Biology & Medicine, 2024, v. 176, n. 3, p. 403, doi. 10.1007/s10517-024-06033-y

By:

Timofeeva, O. S.;
Logvinov, S. V.;
Petrov, I. A.;
Tikhonovskaya, O. A.;
Samoilova, Yu. G.;
Gaifulina, Zh. F.;
Mustafina, L. R.;
Petrova, M. S.;
Zhdankina, A. A.;
Kutsenko, I. G.;
Kudlay, D. A.;
Sidorenkova, K. A.

Publication type:

Article

Gonadotropin-releasing hormone antagonist in in vitro fertilization superovulation.

Published in:

Women's Health (17455057), 2006, v. 2, n. 6, p. 881, doi. 10.2217/17455057.2.6.881

By:

Seng, Shay Way;
Ong, Kee Jiet;
Ledger, W. L.

Publication type:

Article

Usefulness of combined androgen blockade therapy with gonadotropin-releasing hormone antagonist for bone metastatic prostate cancer with pretreatment prostate-specific antigen level ≥ 50 ng/mL.

Published in:

2018

By:

Kashiwabara, Takeshi;
Suda, Sayo

Publication type:

journal article

Analysis of hormone antagonists in clinical and municipal wastewater by isotopic dilution liquid chromatography tandem mass spectrometry.

Published in:

Analytical & Bioanalytical Chemistry, 2010, v. 396, n. 8, p. 2977, doi. 10.1007/s00216-010-3531-0

By:

Xianjun Liu;
Jing Zhang;
Jie Yin;
Hejun Duan;
Yongning Wu;
Bing Shao

Publication type:

Article

Diminished Ovarian Reserve Predisposes to Premature Luteinizing Hormone Surges in Gonadotropin-Releasing Hormone Antagonist Cycles in In vitro Fertilization.

Published in:

Journal of Human Reproductive Sciences, 2020, v. 13, n. 3, p. 191, doi. 10.4103/jhrs.JHRS_133_19

By:

Kochhar, Puneet Kaur;
Ghosh, Pranay

Publication type:

Article

The effect of luteinizing hormone changes in GnRH antagonist protocol on the outcome of controlled ovarian hyperstimulation and embryo transfer.

Published in:

BMC Pregnancy & Childbirth, 2023, v. 23, n. 1, p. 1, doi. 10.1186/s12884-023-05916-8

By:

Zhou, Jing-Shuang;
Chen, Jian-Hong;
Tang, Fei-Fei;
Ou, Jian-Ping;
Tao, Xin;
Cai, Liu-Hong

Publication type:

Article

Considerations for the use of gonadotropin‐releasing hormone agonists and antagonists in patients with prostate cancer.

Published in:

International Journal of Urology, 2020, v. 27, n. 10, p. 830, doi. 10.1111/iju.14303

By:

Van Poppel, Hendrik;
Abrahamsson, Per‐Anders

Publication type:

Article

Relugolix, an oral gonadotropin-releasing hormone (GnRH) receptor antagonist, in women with endometriosis-associated pain: phase 2 safety and efficacy 24-week results.

Published in:

2021

By:

Osuga, Yutaka;
Seki, Yoshifumi;
Tanimoto, Masataka;
Kusumoto, Takeru;
Kudou, Kentarou;
Terakawa, Naoki

Publication type:

journal article

The decrease of serum luteinizing hormone level by a gonadotropin-releasing hormone antagonist following the mild IVF stimulation protocol for IVF and its clinical outcome.

Published in:

Journal of Assisted Reproduction & Genetics, 2008, v. 25, n. 4, p. 115, doi. 10.1007/s10815-008-9205-6

By:

Yanaihara, Atsushi;
Yorimitsu, Takeshi;
Motoyama, Hiroshi;
Ohara, Motohiro;
Kawamura, Toshihiro

Publication type:

Article

The Outcomes of Gonadotropins Releasing hormone Antagonist (GnRH) Cycles with and without letrozole Co-treatment in Patients Undergoing ICSI.

Published in:

Zagazig University Medical Journal, 2024, v. 30, n. 2, p. 576, doi. 10.21608/ZUMJ.2021.87421.2296

By:

El Hamid El Said, Reham Abd;
Sarhan, Abdulmagid Mahmoud;
El Gindy, Eman Amin;
Galal, Ahmed Fawzy;
El Sadek Fakhr, Ahmed Mohamed

Publication type:

Article

The effect of luteal phase gonadotropin-releasing hormone antagonist administration on IVF outcomes in women at risk of OHSS.

Published in:

International Journal of Reproductive Biomedicine, 2016, v. 14, n. 8, p. 507

By:

Eftekhar, Maryam;
Miraj, Sepideh;
Mortazavifar, Zahrasadat

Publication type:

Article

The effect of a transient premature luteinizing hormone surge without elevated serum progesterone on in vitro fertilization outcomes in a gonadotropin-releasing hormone antagonist flexible protocol.

Published in:

Gynecological Endocrinology, 2020, v. 36, n. 6, p. 550, doi. 10.1080/09513590.2019.1683730

By:

Zhang, Duoduo;
Zhang, Dan;
Sun, Zhengyi;
Deng, Chengyan;
Yu, Qi;
Zhen, Jingran

Publication type:

Article

Suppressive effects of linzagolix, a novel non‐peptide antagonist of gonadotropin‐releasing hormone receptors, in experimental endometriosis model rats.

Published in:

Clinical & Experimental Pharmacology & Physiology, 2023, v. 50, n. 7, p. 610, doi. 10.1111/1440-1681.13778

By:

Tezuka, Motohiro;
Tsuchioka, Kumi;
Kobayashi, Kaoru;
Kuramochi, Yu;
Kiguchi, Sumiyoshi

Publication type:

Article

Pharmacological characterization of linzagolix, a novel, orally active, non‐peptide antagonist of gonadotropin‐releasing hormone receptors.

Published in:

Clinical & Experimental Pharmacology & Physiology, 2022, v. 49, n. 10, p. 1082, doi. 10.1111/1440-1681.13688

By:

Tezuka, Motohiro;
Tamai, Yasuaki;
Kuramochi, Yu;
Kobayashi, Kaoru;
Fushimi, Nobuhiko;
Kiguchi, Sumiyoshi

Publication type:

Article

Luteal estradiol supplementation in gonadotropinreleasing hormone antagonist cycles for infertile patients in vitro fertilization.

Published in:

Clinical & Experimental Reproductive Medicine, 2013, v. 40, n. 3, p. 131, doi. 10.5653/cerm.2013.40.3.131

By:

Su-Kyoung Kwon;
Chung-Hoon Kim;
Kyung-Hee Lee;
Il Kyung Jeon;
Jun-Woo Ahn;
Sung-Hoon Kim;
Hee-Dong Chae;
Byung-Moon Kang

Publication type:

Article

Recombinant follicle-stimulating hormone and recombinant luteinizing hormone versus recombinant follicle-stimulating hormone alone during GnRH antagonist ovarian stimulation in patients aged ≥35 years: a randomized controlled trial.

Published in:

Human Reproduction, 2015, v. 30, n. 5, p. 1188, doi. 10.1093/humrep/dev038

By:

Vuong, T. N. L.;
Phung, H. T.;
Ho, M. T.

Publication type:

Article

Ovarian stimulation with HMG: results of a prospective randomized phase III European study comparing the luteinizing hormone-releasing hormone (LHRH)-antagonist cetrorelix and the LHRH-agonist buserelin. European Cetrorelix Study Group.

Published in:

2000

By:

Albano, C;
Felberbaum, R E;
Smitz, J;
Riethmüller-Winzen, H;
Engel, J;
Diedrich, K;
Devroey, P

Publication type:

journal article

High doses of gonadotrophin-releasing hormone antagonist in in-vitro fertilization cycles do not adversely affect the outcome of subsequent freeze-thaw cycles.

Published in:

1999

By:

Kol, S.;
Lightman, A.;
Hillensjo, T.;
Devroey, P.;
Fauser, B.;
Tarlatzis, B.;
Mannaerts, B.;
Itskovitz-Eldor, J.

Publication type:

journal article

Analysis of relative factors and prediction model for optimal ovarian response with gonadotropin-releasing hormone antagonist protocol.

Published in:

Frontiers in Endocrinology, 2022, v. 13, p. 1, doi. 10.3389/fendo.2022.1030201

By:

Wenwen Jiang;
Beihong Zheng;
Xiuhua Liao;
Xiaojing Chen;
Suqin Zhu;
Rongshan Li;
Huale Zhang

Publication type:

Article

The effects of flexible short protocol with gonadotropin-releasing hormone antagonist on preventing premature ovulation in poor responders.

Published in:

Archives of Gynecology & Obstetrics, 2024, v. 309, n. 2, p. 689, doi. 10.1007/s00404-023-07287-z

By:

Zhang, Yan;
Wang, Hongyou;
Zhang, Xinyue;
Hao, Yingying;
Yang, Jihong;
Li, Yangbai;
Feng, Ting;
Chen, Yandong;
Qian, Yun

Publication type:

Article

Editorial Comment to Treatment‐induced changes in levels of brain natriuretic peptide in prostate cancer patients receiving gonadotropin‐releasing hormone antagonists or agonists.

Published in:

International Journal of Urology, 2020, v. 27, n. 4, p. 356, doi. 10.1111/iju.14214

By:

Takahashi, Sayuri

Publication type:

Article

Metabolic stability of long-acting luteinizing hormone-releasing hormone antagonists.

Published in:

Amino Acids, 2012, v. 43, n. 4, p. 1557, doi. 10.1007/s00726-012-1231-0

By:

Yao, Jin-Feng;
Zhou, Ning;
Lv, Yu-Jian;
Zhang, Ruifeng;
Liu, Ke-Liang;
Xue, Ming

Publication type:

Article

Early Follicular Phase Human Chorionic Gonadotropin Addition May Improve the Outcomes of In Vitro Fertilization/Intracytoplasmic Sperm Injection in Patients With "Unpredictable" Poor Response to Gonadotropin-Releasing Hormone Antagonist Protocol.

Published in:

Frontiers in Endocrinology, 2021, v. 12, p. 1, doi. 10.3389/fendo.2021.739773

By:

Zhang, Chunhui;
Wu, Fangrong;
Wu, Zexuan;
Sun, Bolan;
Chen, Cheng;
Qian, Weiping

Publication type:

Article

USE OF AN ISOPROPYL ESTER MOIETY AS A SULFONIC ACID PROTECTING GROUP IN A GREATLY IMPROVED SYNTHESIS OF AN ARYLSULFONIC ACID-BASED FOLLICLE STIMULATING HORMONE ANTAGONIST.

Published in:

Synthetic Communications, 2002, v. 32, n. 17, p. 2695, doi. 10.1081/SCC-120006035

By:

Wrobel, Jay;
Rogers, John;
Green, Daniel;
Kao, Wenling

Publication type:

Article

Gonadotropin--Releasing Hormone Antagonists in Prostate Cancer.

Published in:

Oncology (08909091), 2018, v. 32, n. 12, p. 599

By:

Kittai, Adam S.;
Blank, Jessica;
Graff, Julie N.

Publication type:

Article

Prevention of ovarian hyperstimulation syndrome in a rat model: comparison of the efficacy of tocilizumab with that of ranibizumab, cabergoline, and a gonadotropin-releasing hormone antagonist.

Published in:

Gynecological Endocrinology, 2015, v. 31, n. 12, p. 949, doi. 10.3109/09513590.2015.1077218

By:

Taskin, Mine Islimye;
Topcu, Onur;
Yay, Arzu;
Erken, Gulten;
Balcioğlu, Esra;
Adali, Ertan;
Hismiogulları, Adnan Adil

Publication type:

Article

Effectiveness of a low gonadotrophin-releasing hormone antagonist dose in preventing premature luteinizing hormone rise during controlled ovarian stimulation.

Published in:

Gynecological Endocrinology, 2011, v. 27, n. 11, p. 885, doi. 10.3109/09513590.2011.569601

By:

Tiboni, Gian Mario;
Palumbo, Paola;
Leonzio, Emiliana;
Gabriele, Elisabetta;
Verna, Ilde;
Giampietro, Franca

Publication type:

Article

Controlled ovarian hyperstimulation using multi-dose gonadotropin-releasing hormone (GnRH) antagonist results in less systemic inflammation than the GnRH-agonist long protocol.

Published in:

Gynecological Endocrinology, 2007, v. 23, n. 8, p. 494, doi. 10.1080/09513590701500994

By:

Orvieto, Raoul;
Volodarsky, Michael;
Hod, Eduard;
Homburg, Roy;
Rabinson, Jacob;
Zohav, Efraim;
Anteby, Eyal Y.;
Meltcer, Simion

Publication type:

Article

Pharmacokinetic, Safety, and Pharmacodynamic Properties of Teverelix Trifluoroacetate, a Novel Gonadotropin‐Releasing Hormone Antagonist, in Healthy Adult Subjects.

Published in:

Clinical Pharmacology in Drug Development, 2022, v. 11, n. 2, p. 257, doi. 10.1002/cpdd.1008

By:

MacLean, Carol M.;
Godsafe, Zona;
Soto‐Forte, Pablo;
Larsen, Finn

Publication type:

Article

Delayed Start Protocol with Gonadotropinreleasing Hormone Antagonist in Poor Responders Undergoing In Vitro Fertilization: A Randomized, Doubleblinded, Clinical Trial.

Published in:

Oman Medical Journal, 2018, v. 33, n. 6, p. 506, doi. 10.5001/omj.2018.92

By:

Zarei, Afsoon;
Parsanezhad, Mohammad Ebrahim;
Kutenaei, Maryam Azizi;
Jahromi, Bahia Namavar;
Esfahani, Parastoo Soheil;
Bakhshaei, Pardis

Publication type:

Article